Analysis of risk factors involved in lack of maternal knowledge about neonatal screening
Main Article Content
Abstract
Introduction: neonatal screening, popularly known as ‘heel-stick test’, is designed to detect various pathologies in newborns before the onset of symptoms. Objective: to assess maternal knowledge of neonatal screening and risk factors associated with lack of
information. Methods: a cross-sectional prospective study developed through the appli
cation of a questionnaire with breastfeeding women recruited from public maternity units between 2013 and 2015. Mann-Whitney and chi-square tests were used to verify associations between categorical and continuous variables. Results: 227 questionnaires were validated. Most participants had six or more prenatal appointments, and 3.5% had no pre-natal care. When questioned about the ‘heel-stick test’, 90.7% claimed receiving no information about it during prenatal visits and 17.2% had no knowledge about the topic. Lack of knowledge about neonatal screening was associated with women aged less than 18 years, low education level, primiparity and delivery at high-complexity facilities. Conclusion: prenatal care failed to provide orientation about this intervention. The importance of neo natal screening attests the need to improve guidance to pregnant women, especially tho se in high-risk groups.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Brasil. Triagem neonatal biológica: manual técnico. Brasília: Ministério da Saúde; 2016. 80 p.
2. Leão L, Aguiar M. Newborn screening: what pediatricians should know. Jornal de Pediatria. 2008;84(4):s80-s90.
3. Leonard JV, Morris AA. Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatr. 2006;95(1):6-14.
4. Poretti A, Blaser SI, Lequin MH, Fatemi A, Meoded A, Northington FJ et al. Neonatal neuroimaging findings in inborn errors of metabolism. JJ Magn Reson Imaging. 2013;37(2):294-312.
5. Rubio-Agusti I, Carecchio M, Bhatia KP, Kojovic M, Parees I, Chandrashekar HS et al. Movement disorders in adult patients with classical galactosemia. Mov Disord. 2013;28(6):804-10.
6. Guthrie R, Susi AS. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infant. Pediatrics. 1963;32:338-43.
7. de Carvalho TM, dos Santos HP, dos Santos IC, Vargas PR, Pedrosa J. Newborn screening: a national public health programme in Brazil. J Inherit Metab Dis. 2007;30(4):615.
8. Souza CF, Schwartz IV, Giugliani R. Triagem neonatal de distúrbios metabólicos. Ciênc Saúde Coletiva. 2002;7(1):129-37.
9. Botler J, Camacho LAB, Cruz MM, George P. Triagem neonatal: o desafio de uma cobertura universal e efetiva. Ciênc Saúde Coletiva. 2010;15(2):493-508.
10. Mendes LC, dos Santos TT, Bringel FA. Evolution of the neonatal screening program in the state of Tocantins. Arq Bras Endocrinol Metab. 2013;57(2):112-9.
11. Brasil. Teste do pezinho deve ser feito até o 5º dia de vida do recém-nascido. Brasília: Ministério da Saúde; 2017 [acesso em: 22/11/2017]. Disponível em: http://www.brasil.gov.br/saude/2017/06/teste-do-pezinho-deve-ser-feito-ate-o-5-dia-de-vida-do-recem-nascido
12. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins – Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Practice bulletin n. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127(5):e108-22.
13. Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Braz J Med Biol Res. 2009;42(10):870-6.
14. Haidar FH, Oliveira UF, Nascimento LF. Maternal educational level: correlation with obstetric indicators. Cadernos Saúde Pública. 2001;17(4):1025-9.
15. Al-Sulaiman A, Kondkar AA, Saeedi MY, Saadallah A, Al-Odaib A, Abu-Amero KK. Assessment of the knowledge and attitudes of Saudi mothers towards newborn screening. BioMed Research International. 2015;2015:718674.
16. Burlina AB, Corsello G. Survey of Italian pediatricians' perspectives and knowledge about neonatal screening. Ital J Pediatr. 2015;41:41.
17. Committee on Genetics. Committee opinion n. 616: newborn screening and the role of the obstetrician-gynecologist. Obstet Gynecology. 2015;125(1):256-60.
18. Lang CW, Stark AP, Acharya K, Ross LF. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis. Am J Med Genet A. 2009;149A(11):2424-9.
19. Noke M, Ulph F. Young adults' pre-existing knowledge of cystic fibrosis and sickle cell diseases: implications for newborn screening. J Genetic Couns. 2014;23(1):121-30.
20. Newcomb P, True B, Walsh J, Dyson M, Lockwood S, Douglas B. Maternal attitudes and knowledge about newborn screening. MCN Am J Matern Child Nurs. 2013;38(5):289-94.
21. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system – Executive summary. Pediatrics. 2006;117:S296-S307.
22. Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental views on expanded newborn screening using whole-genome sequencing. Pediatrics. 2016;137(Suppl 1):S36-S46.
23. Botkin JR, Rothwell E, Anderson RA, Rose NC, Dolan SM, Kuppermann M et al. Prenatal education of parents about newborn screening and residual dried blood spots: a randomized clinical trial. JAMA Pediatr. 2016;170(6):543-9.
24. Strekalova YA. Finding motivation: online information seeking following newborn screening for cystic fibrosis. Qual Health Res. 2016;26(9):1180-90.
25. Temme R, Gruber A, Johnson M, Read L, Lu Y, McNamara J. Assessment of parental understanding of positive newborn screening results and carrier status for cystic fibrosis with the use of a short educational video. J Genet Couns. 2015;24(3):473-81.
26. Brousseau T, Sharieff GQ. Newborn emergencies: the first 30 days of life. Pediatr Clin North Am. 2006;53(1)69-84.